10.04.2019 • 09:30 - 11:00 • Plenum
Diskussion - Ein Jahr danach: Auf welchem Weg sind die Biotech-Maßnahmen der Bundesregierung?
Tom Hegermann • Freier Journalist
Tom Hegermann arbeitet als Journalist, Moderator und Trainer. Er hat an der Gesamthochschule Duisburg und der American University in Washington D.C. Politik, Geschichte, Amerikanistik und Journalismus studiert. 25 Jahre lang war er Radio-Moderator bei WDR 2.
Inzwischen ist der Schwerpunkt seiner Arbeit vor allem die Moderation von Kongressen und anderen öffentlichen Veranstaltungen. Außerdem gibt er eine Vielzahl von Seminaren zum Thema „Kommunikation in der Öffentlichkeit“.
Dr. Winfried Horstmann • Bundesministerium für Wirtschaft und Energie
Volker Rieke • Bundesministerium für Bildung und Forschung
Dr. Jan Schmidt-Brand • Heidelberg Pharma AG
Dr Jan Schmidt-Brand has been Chief Executive Officer of Heidelberg Pharma AG since 2014 and Chief Financial Officer since 2012. Until the acquisition by WILEX AG (former name of the Company), Dr Schmidt-Brand held the position of CEO/CFO in the former Heidelberg Pharma GmbH. He has over 25 years’ experience in leading positions in the commercial as well as the fiscal sector of pharmaceutical companies. From 1997 to 2001 he was Managing Director of EBEWE Arzneimittel GmbH, an Austrian BASF Pharma subsidiary. Prior to this, he held several positions at the BASF Group for a total of eight years, most recently as an executive in the central tax department. Dr Jan Schmidt-Brand studied law, business management and French at the universities of Bayreuth and Geneva and obtained his doctoral degree from the University of Mannheim. Since 2007 he has been a member of the board of directors of BIO Deutschland e.V..
Dr. Martina Schraudner • acatech - Deutsche Akademie der Technikwissenschaften
Prof. Dr. Martina Schraudner is the head of the Fraunhofer Center for Responsible Research and Innovation. She joined the acatech‐ Deutsche Akademie der Technikwissenschaften e.V. as a board member in January 2018. After studying biology and biotechnology and graduation at the Technical University of Munich, she has held various positions in the Gesellschaft für Umwelt und Gesundheitsforschung München (gsf), the Eidgenössischen Technischen Universität Zürich (ETH) and Forschungszentrum Jülich (FZJ). Since 2000, she has been part of Fraunhofer's board of directors in research planning to support the development of institutes of the former GMD in the Fraunhofer‐Gesellschaft, and has worked for the advancement of the expansion of the life sciences as well as the development of group medical technology under the guidelines of Fraunhofer.
At the Technical University of Berlin, Prof. Dr. Martina Schraudner leads the department "Gender and Diversity in Technology and Product Development”. She deals with methods, innovations and processes that make diversity accessible to organizations and companies. Prof. Dr. Schraudner is active in national and international committees for applicationoriented research and innovation projects, such as the "Structural Change" group of experts of the EU. She is a member of at the University Council of the University of Paderborn, the board of Trustees of the European Academy for Women in Politics and Business (EAF) and in the executive board of the Kompetenzzentrum Technik‐Diversity‐Chancengleichheit e.V..